• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Clinical Advances in Rosacea Treatment

Clinical Advances in Rosacea Treatment

Video:

 

Specifically engineered for once-daily, non-antibiotic treatment of the inflammatory lesions of rosacea.

 

Supplement:

 

   

Best Practices in the Treatment of Rosacea

In this Dermatology Times supplement, a group of experts in the management and treatment of rosacea discuss the clinical impact of the latest findings regarding understanding of the pathophysiology of the disease, as well as commonly-used therapeutic agents and drug combinations that may be effective in treatment-specific rosacea symptoms.

Learning objectives:

  • Discuss new insights regarding the pathophysiology of rosacea, as well as genetic predisposing factors that have been linked to its development
  • Assess opportunities to incorporate rosacea phenotyping into the treatment plan for patients presenting with various signs and symptoms
  • Determine effective techniques to present appropriate short- and long-term treatment goals for patients with rosacea
  • Analyze situations in which the use of low-dose doxycycline would be most appropriate in the treatment of rosacea

Download Supplement

  

Related Articles:

 

 

 

Lisette Hilton

Links shown between rosacea, other diseases

 

Lisette Hilton

Rosacea and gastro disorders possibly related

 

Lisette Hilton

Updated guidelines for diagnosis, treatment of rosacea

 

John Jesitus

Factors in rosacea pathogenesis clearer

Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.